Global Microbiome Sequencing Services Market

1 INTRODUCTION OF GLOBAL MICROBIOME SEQUENCING SERVICESMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL MICROBIOME SEQUENCING SERVICESMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY END USER:
5.1 Pharmaceutical and Biotechnology Companies
5.2 Academia/Research Institutes

6 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION:
6.1 Shotgun Sequencing
6.2 Targeted Gene Sequencing
6.3 Rna Sequencing
6.4 Whole Genome Sequencing
6.5 Other Applications

7 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY:
7.1 Sequencing By Synthesis (SBS)
7.2 Sequencing By Ligation (SBL)
7.3 Pyrosequencing
7.4 Sanger Sequencing
7.5 Other Technologies

8 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY LABORATORY TYPE:
8.1 Wet Labs
8.2 Dry Labs

9 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY RESEARCH TYPE:
9.1 Outsourced
9.2 Internal

10 GLOBAL MICROBIOME SEQUENCING SERVICESMARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

11 GLOBAL MICROBIOME SEQUENCING SERVICESMARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES
12.1 Baseclear B.V.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments

12.2 Clinical-Microbiomics A/S
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments

12.3 Molzym GmbH & Co. Kg
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments

12.4 Zymo Research Corp.
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments

12.5 Rancho Biosciences
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments

12.6 Microbiome Therapeutics, LLC.
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments

12.7 Microbiome Insights Inc.
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments

12.8 Openbiome
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments

12.9 Resphera Biosciences, LLC.
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments

12.10 MR DNA (Molecular Research Lp)
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments

12.11 Ubiome, Inc.
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments

12.12 Shanghai Realbio Technology Co., Ltd
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments

12.13 Diversigen, Inc.
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments

12.14 MerieuxNutrisciences Corporation
12.14.1 Overview
12.14.2 Financial Performance
12.14.3 Product Outlook
12.14.4 Key Developments

12.15 Metabiomics Corp.
12.15.1 Overview
12.15.2 Financial Performance
12.15.3 Product Outlook
12.15.4 Key Developments

13 Appendix
13.1 Related Reports